Abstract: Background: Sentinel lymph node biopsy in thin invasive primary cutaneous melanoma (up to 1mm thick) is a controversial subject. The presence of tumor-infiltrating lymphocytes could be a factor to be considered in the decision to perform this procedure. oBjective: To evaluate the association between the presence of tumor-infiltrating lymphocytes and lymph node metastases caused by thin primary cutaneous melanoma. Methods: Cross-sectional study with 137 records of thin invasive primary cutaneous melanoma submitted to sentinel lymph node biopsy from 2003 to 2015. The clinical variables considered were age, sex and topography of the lesion. The histopathological variables assessed were: tumor-infiltrating lymphocytes, melanoma subtype, Breslow thickness, Clark levels, number of mitoses per mm², ulceration, regression and satellitosis. Univariate analyzes and logistic regression tests were performed as well the odds ratio and statistical relevance was considered when p <0.05. results: Among the 137 cases of thin primary cutaneous melanoma submitted to sentinel lymph node biopsy, 10 (7.3%) had metastatic involvement. Ulceration on histopathology was positively associated with the presence of metastatic lymph node, with odds ratio =12.8 (2.77-59.4 95% CI, p=0.001). The presence of moderate/marked tumor-infiltrating lymphocytes was shown to be a protective factor for the presence of metastatic lymph node, with OR=0.20 (0.05-0.72 95% CI, p=0.014). The other variables -clinical and histopathological -were not associated with the outcome. study liMitations: The relatively small number of positive sentinel lymph node biopsy may explain such an expressive association of ulceration with metastatization. conclusions: In patients with thin invasive primary cutaneous melanoma, few or absent tumor-infiltrating lymphocytes, as well as ulceration, represent independent risk factors for lymph node metastasis.
INTRODUCTION
Early diagnosis of melanoma is a vital necessity in view of the reduced survival with the progression of the disease. In invasive early lesions, i.e., up to 1mm thickness and not in situ, lymph node involvement is one of the main prognostic factors.
1,2 Thus, tumors classified as T1 (≤ 1mm thick) by the American Joint Committee on Cancer (AJCC), despite representing the majority of melanomas (63%), can belong to clinical stage III (due to lymph node involvement) and patients have their 5-year survival significantly reduced (98.9% for T1a and 93.7% for T1b) to 53.7%. 3, 4 This explains the fact that thin melanomas being responsible for up to 25% of death caused by this disease. 3 An Bras Dermatol. 2019;94 (1) :47-51.
The recommendation for sentinel lymph node biopsy (SLNB) in a thin cutaneous melanoma (≤ 1mm) is controversial, since some authors consider the chance of lymph node involvement to be low in this group, particularly when the thickness is of less than 0.75mm. [5] [6] [7] [8] [9] [10] On the other hand, some authors present data that add to the existing doubts on the subject. The main objective of this study was to investigate the relationship between metastatic involvement of sentinel lymph node and the presence and intensity of tumor-infiltrating lymphocytes.
The secondary objectives were to compare the other clinical characteristics and pathological microstaging with the same outcome. For the statistical analysis, the level of significance adopted was 5% (p<0.05) and the analyses were made using the program 
METHODS
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RESULTS
The mean age of the patients in the study was 53 years, with a non-significant predominance of females. The trunk was the site most affected by melanoma and the most frequent type of melanoma was the superficial spreading type (Table 1) .
One hundred and thirty-seven cases of TPCM that had protocol indication for the procedure were submitted to SNLB (presence of ulceration, mitosis, thickness more than 0.75mm, regression), among which 10 (7.3%) had metastatic lymph node involvement.
After multivariate regression analysis, only two factors had statistical significance. The group that had moderate and marked TIL showed a reduction in the risk of sentinel lymph node involvement, 
DISCUSSION
In the present study, the presence of moderate/marked TIL was a protection factor for the presence of metastatic lymph node.
Patients with moderate/marked TIL in the primary melanoma lesion had a five-fold lower risk for the presence of one positive lymph node when compared to individuals with absent or few TIL in the lesion.
An increasing number of studies show that the individual immune response related to TIL can yield consistent results regarding improved survival, defining TIL as a prognostic factor. 
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It is extremely important to consider that local control of the disease in patients with lymph node involvement can improve disease-and recurrence-free survival when done early (SNLB followed by lymphadenectomy), with better local control of the disease (avoiding lymph node tumor masses, many times associated to ulceration, infection and bleeding, situations of difficult clinical management and great suffering for the patient), despite not improving overall. [28] [29] [30] [31] [32] [33] [34] [35] As limitation of the study, the coherence with studies by
Azimi et al. 18 and Fortes et al. 19 in the characterization of ulceration as a risk factor for sentinel lymph node should be evaluated carefully, because even by demonstrating a significantly high risk (12.8-fold), the number of cases of ulcerated melanomas was small in both groups.
In the present study with 137 TPCM cases, we observed that the risk for SLNB positivity is not negligible (7.3%) and regardless of other risk factors, absent or few TIL presents as a risk factor for sentinel lymph node positivity on TPCM. Thus, it is important to take TIL into consideration in the group of information that will define which TPCM can benefit from SLNB.
CONCLUSION
The evaluation of the presence and intensity of TIL in invasive TPCM patients can help in the decision-making to perform SLNB. q
